P
PHARVARIS BV
NASDAQ: PHVS (Pharvaris N.V.)
Kemas kini terakhir: 10 jam lalu30.02
0.00 (0.00%)
| Penutupan Terdahulu | 30.02 |
| Buka | 30.06 |
| Jumlah Dagangan | 538,117 |
| Purata Dagangan (3B) | 203,047 |
| Modal Pasaran | 1,963,542,912 |
| Harga / Buku (P/B) | 6.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2026 |
| EPS Cair (TTM) | -3.27 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.33% |
| Nisbah Semasa (MRQ) | 11.10 |
| Aliran Tunai Operasi (OCF TTM) | -134.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -79.65 M |
| Pulangan Atas Aset (ROA TTM) | -31.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -52.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Pharvaris N.V. | Menaik | Menaik |
AISkor Stockmoo
0.8
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -5.0 |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.80 |
|
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 6.25% |
| % Dimiliki oleh Institusi | 89.49% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| General Atlantic, L.P. | 31 Dec 2025 | 8,031,252 |
| Foresite Capital Management Iv, Llc | 31 Dec 2025 | 4,778,581 |
| Venbio Partners Llc | 31 Dec 2025 | 4,639,304 |
| Viking Global Investors Lp | 31 Dec 2025 | 3,653,310 |
| Eqt Fund Management S.A R.L. | 31 Dec 2025 | 3,424,609 |
| Deerfield Management Company, L.P. | 31 Dec 2025 | 3,126,042 |
| Bain Capital Life Sciences Investors, Llc | 31 Dec 2025 | 2,802,081 |
| Novo Holdings A/S | 31 Dec 2025 | 1,750,000 |
| Saturn V Capital Management Lp | 31 Dec 2025 | 1,140,033 |
| Cormorant Asset Management, Lp | 31 Dec 2025 | 1,083,000 |
| 5Am Venture Management, Llc | 31 Dec 2025 | 797,600 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (HC Wainwright & Co., 99.87%) | Beli |
| Median | 56.00 (86.54%) | |
| Rendah | 52.00 (RBC Capital, 73.22%) | Beli |
| Purata | 56.00 (86.54%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 26.64 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| RBC Capital | 09 Mar 2026 | 52.00 (73.22%) | Beli | 26.51 |
| HC Wainwright & Co. | 03 Mar 2026 | 60.00 (99.87%) | Beli | 26.78 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| LESAGE ANNE | - | 29.50 | -59,300 | -1,819,718 |
| LU PENG | - | 29.54 | -25,834 | -789,544 |
| SCHIKAN JOHANNES GERARDUS CHRISTIAAN PETRUS | - | 29.54 | -40,000 | -1,228,719 |
| Jumlah Keseluruhan Kuantiti Bersih | -125,134 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -3,837,981 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 29.52 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| LU PENG | Pegawai | 30 Apr 2026 | Jual automatik (-) | 15,000 | 31.01 | 465,150 |
| LU PENG | Pegawai | 30 Apr 2026 | Pelaksanaan pilihan | 15,000 | - | - |
| LESAGE ANNE | Pegawai | 30 Apr 2026 | Jual automatik (-) | 21,700 | 31.01 | 672,917 |
| LESAGE ANNE | Pegawai | 30 Apr 2026 | Jual automatik (-) | 19,200 | 31.01 | 595,392 |
| LESAGE ANNE | Pegawai | 30 Apr 2026 | Pelaksanaan pilihan | 21,700 | - | - |
| SCHIKAN JOHANNES GERARDUS CHRISTIAAN PETRUS | Pengarah | 30 Apr 2026 | Jual automatik (-) | 29,070 | 31.01 | 901,461 |
| LU PENG | Pegawai | 29 Apr 2026 | Jual automatik (-) | 3,733 | 29.83 | 111,355 |
| LU PENG | Pegawai | 29 Apr 2026 | Pelaksanaan pilihan | 3,733 | - | - |
| LESAGE ANNE | Pegawai | 29 Apr 2026 | Jual automatik (-) | 3,700 | 29.83 | 110,371 |
| LESAGE ANNE | Pegawai | 29 Apr 2026 | Pelaksanaan pilihan | 3,700 | - | - |
| SCHIKAN JOHANNES GERARDUS CHRISTIAAN PETRUS | Pengarah | 29 Apr 2026 | Jual automatik (-) | 3,830 | 29.83 | 114,249 |
| LU PENG | Pegawai | 23 Apr 2026 | Jual automatik (-) | 100 | 27.29 | 2,729 |
| LU PENG | Pegawai | 23 Apr 2026 | Pelaksanaan pilihan | 100 | - | - |
| LESAGE ANNE | Pegawai | 23 Apr 2026 | Jual (-) | 100 | 27.29 | 2,729 |
| LESAGE ANNE | Pegawai | 23 Apr 2026 | Jual automatik (-) | 100 | 27.29 | 2,729 |
| LESAGE ANNE | Pegawai | 23 Apr 2026 | Pelaksanaan pilihan | 100 | - | - |
| SCHIKAN JOHANNES GERARDUS CHRISTIAAN PETRUS | Pengarah | 23 Apr 2026 | Jual automatik (-) | 100 | 27.29 | 2,729 |
| LU PENG | Pegawai | 22 Apr 2026 | Jual automatik (-) | 7,001 | 30.04 | 210,310 |
| LU PENG | Pegawai | 22 Apr 2026 | Pelaksanaan pilihan | 7,001 | - | - |
| LESAGE ANNE | Pegawai | 22 Apr 2026 | Jual automatik (-) | 7,500 | 30.04 | 225,300 |
| LESAGE ANNE | Pegawai | 22 Apr 2026 | Jual (-) | 7,000 | 30.04 | 210,280 |
| LESAGE ANNE | Pegawai | 22 Apr 2026 | Pelaksanaan pilihan | 7,500 | - | - |
| SCHIKAN JOHANNES GERARDUS CHRISTIAAN PETRUS | Pengarah | 22 Apr 2026 | Jual automatik (-) | 7,000 | 30.04 | 210,280 |
| Papar semua | ||||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |